Houston IP boutique described as ‘powerful and balanced team’ in exclusive rankings HOUSTON – Heim, Payne & Chorush and firm co-founders Mike Heim and Les Payne have earned repeat recognition from the prestigious Chambers USA legal guide, honored for their expertise in patent litigation. In the 2021 legal guide, the firm moved up in the rankings and is one of only 11 Texas ranked firms
Read moreHeim, Payne & Chorush partners Blaine Larson and Allan Bullwinkel have earned repeat selection to the Super Lawyers Rising Stars list of the state’s top young lawyers. The Texas Rising Stars list recognizes the outstanding work of the state’s top attorneys under the age of 40 or those who have practiced law for no more than 10
Read moreHeim, Payne & Chorush is a proud supporter of Weatherford International’s annual Weatherford Walks fundraiser. Although this year’s walkathon was forced to go virtual because of the pandemic, participants still logged nearly 3,300 miles throughout the entire month of November to raise awareness and more than $381,000 for four Houston-area nonprofits. Since its inception, Weatherford Walks has raised more than $2.28 million for
Read moreHouston IP boutique recognized for activity, performance in Patexia Insights analysis HOUSTON – Heim, Payne & Chorush is again ranked among the most-active and top–performing intellectual property law firms in the nation for critically important post-grant inter partes review proceedings based on a comprehensive analysis by Patexia Insights. The Houston-based patent litigation boutique is among the Top 100 in the U.S. in an analysis based on filings for patent owners, patent petitioners and case outcomes, as well as an overall category that aggregates all the variables. Results of
Read moreHouston patent litigation boutique recognized for role in record $750M Namenda settlement HOUSTON — Heim, Payne & Chorush, LLP, has earned the American Antitrust Institute’s 2020 Antitrust Enforcement Award for the firm’s role in a record $750 million settlement with pharmaceutical company Allergan in patent-related antitrust litigation related to the Alzheimer’s drug Namenda. The January
Read moreHouston boutique retains top-tier Best Law Firms ranking based on client, peer review HOUSTON – U.S. News & World Report and The Best Lawyers in America have named Heim, Payne & Chorush among the nation’s top patent and intellectual property litigation firms on the 2021 Best Law Firms list, one of the nation’s most prestigious and respected guides to the legal profession. The firm earned top-tier rankings nationally and in the Houston legal market for patent
Read moreAs part of a pre-election series focusing on how the outcome of the presidential race could impact various practice areas, Texas Lawyer newspaper published an article by Heim, Payne & Chorush partner Eric Enger exploring intellectual property law issues at play, including ramifications for international patents and IP theft, domestic patents, copyrights, trademarks and noncompete
Read moreTexas Lawyer magazine spotlights firm co-founders as ‘agents of change’ HOUSTON – Heim, Payne & Chorush is proud to announce that firm co-founders Russell Chorush and Les Payne have been recognized as “IP Trailblazers” by Texas Lawyer magazine. Featured in the October issue of the legal news publication, the Trailblazers list honors “agents of change”
Read moreLaw 360 recently interviewed Heim, Payne & Chorush co-founder and managing partner Mike Heim for an analysis examining the role of patent law and regulation in the escalating debate over drug-pricing. The analysis by Law360 senior reporter Ryan Davis explores a number of recent legislative proposals, noting that bipartisan scrutiny is likely to increase after
Read morePatent litigation veterans selected by peers for statewide recognition HOUSTON – Four partners from Heim, Payne & Chorush have been named among the state’s top attorneys in the 2020 ranking by Super Lawyers, a prestigious guide that recognizes no more than 5 percent of Texas attorneys each year. Firm co-founders Mike Heim, Russell Chorush and
Read more
